Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verona Pharma plc

104.90
-0.00500.00%
Volume:1.61M
Turnover:169.14M
Market Cap:8.93B
PE:-51.99
High:105.00
Open:104.90
Low:104.87
Close:104.90
Loading ...

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading

MT Newswires Live
·
28 Apr

Verona Pharma PLC expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
25 Apr

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires

Insider Monkey
·
24 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

Cantor Fitzgerald Initiates Verona Pharma at Overweight

MT Newswires Live
·
21 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense

MT Newswires Live
·
28 Mar

Verona Pharma Announces Amended Strategic Financing With Oaktree And OMERS

Reuters
·
28 Mar

Press Release: Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Dow Jones
·
28 Mar

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”

Insider Monkey
·
27 Mar

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
10 Mar

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live
·
07 Mar

Verona Pharma plc (VRNA): A Bull Case Theory

Insider Monkey
·
05 Mar

BTIG Sticks to Its Buy Rating for Verona Pharma (VRNA)

TIPRANKS
·
05 Mar

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading

MT Newswires Live
·
04 Mar

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus

Zacks
·
03 Mar

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.
·
02 Mar

Verona Pharma price target raised to $76 from $57 at Truist

TIPRANKS
·
01 Mar